Ausdal Financial Partners, Inc. Eli Lilly & CO Transaction History

Ausdal Financial Partners, Inc.

$897 Million
Q3 2024

A detailed history of Ausdal Financial Partners, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Ausdal Financial Partners, Inc. holds 3,397 shares of LLY stock, worth $2.54 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

3,397

Previous 3,142 8.12%

Holding current value

$2.54 Million

Previous $2.84 Million 5.8%

% of portfolio

0.34%

Previous 0.32%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$772.14 - $960.02 $196,895 - $244,805	255 Added 8.12%	3,397 $3.01 Million
Q2 2024 Aug 06, 2024	SELL	$724.87 - $909.04 $97,857 - $122,720	-135 Reduced 4.12%	3,142 $2.84 Million
Q1 2024 Apr 12, 2024	BUY	$592.2 - $792.28 $17,173 - $22,976	29 Added 0.89%	3,277 $2.55 Million
Q4 2023 Jan 11, 2024	BUY	$525.19 - $619.13 $92,433 - $108,966	176 Added 5.73%	3,248 $1.89 Million
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $37,384 - $51,539	-86 Reduced 2.72%	3,072 $1.65 Million
Q2 2023 Jul 31, 2023	BUY	$350.74 - $468.98 $61,379 - $82,071	175 Added 5.87%	3,158 $1.48 Million
Q1 2023 May 04, 2023	SELL	$310.63 - $364.82 $34,169 - $40,130	-110 Reduced 3.56%	2,983 $1.02 Million
Q4 2022 Feb 03, 2023	BUY	$321.55 - $374.67 $218,332 - $254,400	679 Added 28.13%	3,093 $1.13 Million
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $28,758 - $32,773	97 Added 4.19%	2,414 $781,000
Q1 2022 May 04, 2022	BUY	$234.69 - $291.66 $70,641 - $87,789	301 Added 14.93%	2,317 $663,000
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $20,236 - $25,113	-90 Reduced 4.27%	2,016 $557,000
Q3 2021 Nov 01, 2021	SELL	$221.6 - $272.71 $30,137 - $37,088	-136 Reduced 6.07%	2,106 $487,000
Q2 2021 Jul 19, 2021	SELL	$180.55 - $233.54 $48,567 - $62,822	-269 Reduced 10.71%	2,242 $515,000
Q1 2021 May 05, 2021	BUY	$164.32 - $212.72 $39,601 - $51,265	241 Added 10.62%	2,511 $469,000
Q4 2020 Feb 01, 2021	BUY	$130.46 - $172.63 $25,178 - $33,317	193 Added 9.29%	2,270 $383,000
Q3 2020 Nov 04, 2020	BUY	$146.22 - $169.13 $30,267 - $35,009	207 Added 11.07%	2,077 $307,000
Q1 2020 May 04, 2020	SELL	$119.05 - $147.35 $44,643 - $55,256	-375 Reduced 16.7%	1,870 $295,000
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $34,107 - $42,245	-319 Reduced 12.44%	2,245 $314,000
Q2 2019 Aug 05, 2019	BUY	$110.79 - $129.32 $25,481 - $29,743	230 Added 9.85%	2,564 $279,000
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $31,945 - $37,602	-287 Reduced 10.95%	2,334 $303,000
Q4 2018 Feb 11, 2019	SELL	$105.9 - $118.64 $65,234 - $73,082	-616 Reduced 19.03%	2,621 $303,000
Q3 2018 Nov 09, 2018	BUY	$85.86 - $107.31 $5,924 - $7,404	69 Added 2.18%	3,237 $347,000
Q2 2018 Aug 08, 2018	SELL	$75.7 - $86.88 $32,172 - $36,924	-425 Reduced 11.83%	3,168 $270,000
Q1 2018 Apr 20, 2018	BUY	$74.21 - $87.6 $40,370 - $47,654	544 Added 17.84%	3,593 $278,000
Q4 2017 Feb 08, 2018	BUY	$81.94 - $87.89 $81 - $87	1 Added 0.03%	3,049 $258,000
Q3 2017 Oct 31, 2017	BUY	$77.07 - $85.54 $234,909 - $260,725	3,048	3,048 $261,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ausdal Financial Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ausdal Financial Partners, Inc. with notifications on news.

Account

Ausdal Financial Partners, Inc. Eli Lilly & CO Transaction History